Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility to Syngene International, a leading ...

The Food and Drug Administration announced Monday it has approved a product called Botox Cosmetic to treat moderate to severe frown lines between the eyebrows. Botox is made from the toxin that causes ...

Rare diseases - a medical condition so obscure that even your doctor has to Google. Despite their name, these diseases ...

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...